Saal, Kim-Ann <br/><br/>
AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo.  [electronic resource] 

 -  Neurobiology of disease  Jan 2015 
 - 150-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-953X 
<br/><br/><label>Standard No.: </label>10.1016/j.nbd.2014.09.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3,4-Dihydroxyphenylacetic Acid--metabolism<br/>Adrenergic Agents--toxicity<br/>Animals<br/>Dependovirus--genetics<br/>Disease Models, Animal<br/>Dopaminergic Neurons--metabolism<br/>Down-Regulation--genetics<br/>Genetic Vectors--physiology<br/>Homovanillic Acid<br/>Lim Kinases--genetics<br/>Nerve Degeneration--etiology<br/>Oxidopamine--toxicity<br/>Parkinson Disease--complications<br/>Psychomotor Performance<br/>RNA, Small Interfering--genetics<br/>Rats<br/>Rats, Wistar<br/>Substantia Nigra--pathology<br/>Tyrosine 3-Monooxygenase<br/>rho-Associated Kinases--genetics